743 results about "Poly l lactic acid" patented technology

The invention discloses a preparation method of a curing agent with biological self-healing capability, which comprises the following steps: preparing a bacillus pasteurii bacterial solution, preparing the bacillus pasteurii bacterial solution into an endophytic spore solution, immersing polyvinyl alcohol fibers into a sodium alginate / endophytic spore solution, taking out the polyvinyl alcohol fibers, immediately immersing the polyvinyl alcohol fibers into a calcium acetate solution, drying the polyvinyl alcohol fibers to obtain core fibers with a hydrogel coating, and curing the core fibers with the hydrogel coating to obtain the curing agent with biological self-healing capability. The preparation method comprises the following steps: taking magnesium phosphate cement as a raw material, immediately immersing the magnesium phosphate cement into a chloroform solution of a polystyrene and polylactic acid polymer blend, drying to obtain a coated microbial liquid, premixing urea and glucose, doping the premixed urea and glucose into the magnesium phosphate cement, uniformly stirring, adding the coated microbial liquid, and uniformly stirring to obtain the product. According to the invention, phosphate cement is adopted as the curing agent, has the advantages of high strength, short setting time, strong durability, low alkalinity, good biocompatibility and the like, and compared with the curing agent in the prior art, the curing agent not only has a good curing effect, but also has a crack self-healing function, and is especially suitable for reinforcing foundation soil.

The invention discloses an absorbable suture line for surgical suture and a preparation method thereof, and relates to the technical field of medical materials. The absorbable suture line for surgical suture is prepared from the following raw materials in parts by weight: 50 to 65 parts of polylactic acid, 15 to 20 parts of polyglycolic acid, 3 to 5 parts of sodium carboxymethyl cellulose, 3 to 8 parts of a toughening agent, 3 to 6 parts of an antibacterial agent, 0.3 to 0.8 part of a lubricating agent, 1 to 2 parts of sodium hyaluronate and 5 to 10 parts of polyvinyl alcohol. The toughening agent is obtained by reacting hydroxyethyl acrylate with ethylenediamine to generate a four-arm compound and then reacting with 6-caprolactone and DL-lactide. The absorbable suture line for surgical suture prepared by the invention has excellent tensile property and antibacterial property, and can meet the application requirements of clinical medical treatment.

The invention discloses a neuraminidase-targeted drug-loaded nanoparticle as well as a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations. Polysialic acid and poly (lactic-co-glycolic acid) are connected through ester bond connection to obtain the drug-loaded nanoparticles with stable structure and performance, and the drug-loaded nanoparticles have the effect of targeting neuraminidase and also have high efficiency of entering cells; the antibiotic drug is further dispersed in the drug-loaded nanoparticles, the inflammation regulating agent is adsorbed on the surface of the drug-loaded nanoparticles, and the drug-loaded nanoparticles can deliver the antibiotic drug and the inflammation regulating agent to the pig Gleisseria in the pig body. According to the present invention, the antibiotic drug and the inflammation regulating agent are released under the acidic environment at the infection site in the pig body, such that the pig Gleisseria is efficiently killed, the inflammation damage caused by bacterial infection and the toxic damage of the antibiotic drug are reduced, and the good application prospect is provided in the preparation of the drug for preventing and / or treating the pig Gleisseria infection.

The invention relates to the field of sponge materials, and provides an antibacterial degradable sponge material and a preparation method thereof. The material is prepared from protocatechuic acid modified quaternized chitosan, quaternary ammonium salt grafted gelatin, sodium alginate, polyhydroxybutyrate, polycaprolactone, a polylactic acid-glycolic acid copolymer, hexamethylene diisocyanate, a foaming agent, nano cellulose, vitamin E, polyethylene glycol, triethylamine and dimethylformamide. Protocatechuic acid and quaternized chitosan are subjected to amidation modification, and chitosan and gelatin are subjected to quaternization treatment by adopting 2, 3-epoxypropyl trimethyl ammonium chloride, so that the antibacterial property and biodegradability of the material are improved. In the material preparation process, through vacuum degassing, foaming vacuum degree and humidity control and a multi-step drying process, it is ensured that the average pore size of the material is uniform (50-200 microns) and the porosity is high (50%-90%), and the obtained material has excellent antibacterial property and degradability and has wide application value.

The invention relates to an oral mucosa repairing medicine and a preparation method thereof, and belongs to the technical field of medicines, the medicine comprises barnacle peptide, salivary lactobacillus, resveratrol, a biphasic adhesion matrix, hydroxyapatite, vitamin B family and other components. The preparation method comprises the following steps: sequentially carrying out enzymolysis on barnacle gooseneck by pepsin and lumbrukinase to obtain barnacle peptide. The double-phase adhesion matrix comprises a water-phase matrix, an oil-phase matrix and lecithin; the water-phase matrix contains a chondroitin sulfate-chitosan quaternary ammonium salt compound, sodium alginate and other components; the oil-phase matrix comprises sesame oil, beeswax, a polylactic acid-glycolic acid copolymer and the like. According to the invention, barnacle peptide and salivary lactobacillus are prepared by adopting a special method and are matched with resveratrol for use, so that multi-target and multi-path promotion of oral mucosa repair can be realized; the chondroitin sulfate-chitosan quaternary ammonium salt compound is prepared through electrostatic and physical embedding, the chondroitin sulfate-chitosan quaternary ammonium salt compound is matched with other components to prepare the biphasic adhesion matrix, the biocompatibility is good, the adhesion is high, and the action time of a sustained-release drug is well prolonged.

The invention relates to medical recombinant collagen repair gel and a preparation method thereof, and belongs to the technical field of recombinant collagen. Through the synergistic effect of the collagen, the chitosan, the polylactic acid, the nanocellulose, the vascular endothelial growth factor, the anti-inflammatory drug and the cell adhesion peptide, the tissue repair effect is remarkably improved. Through a gas foaming method, staged freezing and freeze drying, multistage pore size distribution is generated, gel with a porous structure is formed, and cell permeation and tissue regeneration are facilitated; in addition, the permeability and the drug loading capacity of the gel are improved, the cell adhesion peptides, the growth factors and the anti-inflammatory drugs are better adsorbed to the gel, functional slow release is achieved, and the repairing effect is further improved.

The invention relates to the technical field of functional composite materials, and discloses a preparation method of polylactic acid porous microspheres and application of the polylactic acid porous microspheres in stem cell inoculation, and the preparation method comprises the following steps: (1) dissolving chitosan in an acetic acid aqueous solution, adding bioactive glass nanoparticles, and performing ultrasonic treatment to obtain an aqueous phase solution; (2) dissolving PLGA or PLA in dichloromethane, and adding an emulsifier to obtain an oil phase solution; (3) dropwise adding the water-phase solution into the oil-phase solution to obtain a water-in-oil primary emulsion; (4) dropwise adding the water-in-oil primary emulsion into a PVA aqueous solution to obtain a double emulsion; and (5) stirring the double emulsions, carrying out centrifugal separation, drying, and immersing in a glutaraldehyde solution for cross-linking treatment to obtain the porous microspheres. The porous microspheres are prepared by a double-emulsion solvent evaporation method, and have more uniform pore size distribution and higher biological activity, so that the porous microspheres can be used as an excellent stem cell inoculation carrier to meet the attachment and proliferation of high-proportion cells.

The invention relates to the technical field of biomedical materials, in particular to an artificial bone composite material and a preparation method thereof. The preparation method of the artificial bone composite material comprises the following steps: sequentially adding a CaCl2 solution and a NaH2PO4 solution into a collagen solution in proportion. And adjusting the pH value to 7.4, and collecting white jelly. Dispersing the white jelly in distilled water to obtain a colloid I; respectively adding the colloid I and the modified polyether-ether-ketone powder into a dichloromethane solution containing poly-L-lactic acid in proportion to obtain a mixed solution II, and then adding an ethanol solution for precipitation; and removing the precipitate in the mixed solution II to obtain the slurry. Injecting the slurry into a mold to obtain an intermediate I, and soaking the intermediate I in an EDC / NHS ethanol solution for crosslinking; according to the preparation method, the artificial bone composite material with high mechanical strength and good biocompatibility can be prepared, the defect that the biocompatibility and mechanical strength resistance of the artificial bone composite material cannot be obtained at the same time in the prior art can be overcome, and the practicability of the artificial bone composite material is improved.

The invention discloses an artificial bone for promoting osteoporotic bone defect repair and a preparation method thereof, and belongs to the technical field of biomedical materials. The artificial bone disclosed by the invention is prepared by compounding the following components in percentage by weight: 89.65 to 89.85 weight percent of polylactic acid-glycolic acid copolymer, 9.85 to 10.15 weight percent of nano hydroxyapatite and 0.1 to 0.5 weight percent of zoledronic acid. In the artificial bone, the nano-hydroxyapatite and zoledronic acid are uniformly dispersed in the polylactic acid-glycolic acid copolymer, and the porous structure on the surface of the artificial bone is combined, so that osteoblasts can be attached to the surface of the artificial bone, and new bone tissues can grow in the artificial bone; phosphonate radicals of zoledronic acid can be chelated with nano-hydroxyapatite to generate stable chemical bonds, the stable chemical bonds are introduced into the polylactic acid-glycolic acid copolymer, effective loading of zoledronic acid can be achieved, and the effective loading of zoledronic acid can inhibit bone resorption increase caused by overactivation of osteoclasts and repair osteoporotic bone defects.

The invention relates to the technical field of biomedicine, and discloses a triclosan antibacterial coating surgical suture and a preparation method thereof.The suture comprises a base material and a surface antibacterial coating, the base material is selected from one of an absorbable single-strand material, an absorbable multi-strand material, a non-absorbable single-strand material and a non-absorbable multi-strand material, and the surface antibacterial coating is selected from one of an absorbable multi-strand material and a non-absorbable multi-strand material; the antibacterial coating comprises triclosan, a high-molecular carrier and an auxiliary agent, the surface energy of a hydrophobic material is improved, the porosity of a hydrophilic material is increased, the adhesive force between the coating and different base materials is ensured, the base materials can be covered, the uniformity deviation of the coating is avoided, and the coating is free of cracking or falling off through the combination of plasma cleaning and roughening treatment on the surface of the base materials. A synergistic system is formed by triclosan, nano-silver and titanium dioxide, a dual mechanism of targeted destruction of bacterial cell membranes and free radical oxidation is achieved, the antibacterial rate is increased, the MRSA inhibition rate is increased, the degradation rate is regulated and controlled through the polylactic acid-glycolic acid copolymer carrier molecular weight and the lactic acid / glycolic acid proportion, and a curing dynamic formula is combined.

The invention belongs to the technical field of sensors and intelligent wearable electronics, and discloses a nano-fiber-based composite material with a cobweb structure as well as a preparation method and application of the nano-fiber-based composite material. Preparing a Cu < 2 + >-doped polylactic acid porous nanofiber membrane by utilizing electrostatic spinning, and spraying copper conductive ink in the spinning process; and then hydrogel is sprayed and cross-linked to obtain the nanofiber strain sensor with a cobweb structure. Under the action of strong surface energy of a porous nanofiber interface, the copper conductive ink forms a linear continuous conductive area depending on fiber appearance, a flaky conductive area is constructed by enrichment distribution of the conductive ink at the junction of fibers, and the linear and flaky areas are in network connection in the polylactic acid porous nanofiber membrane. A bionic cobweb structure electric signal transmission structure model is constructed, hydrogel is sprayed to enable the structure to be crosslinked and wound, and the nanofiber-based high-sensitivity strain sensor which is high in toughness, resistant to fatigue and excellent in human skin attaching capacity is obtained. The preparation method is simple, low in cost, high in toughness, resistant to fatigue, excellent in human skin attaching capacity, high in sensitivity and wide in application range, and can be used for physiological health detection and wearable electronic equipment.

The invention provides a preparation method of antibacterial degradable fibers. The preparation method comprises the following steps: adding chitosan and citric acid into a polyethylene glycol solution, and uniformly stirring to obtain an antibacterial polyvinyl alcohol solution; the preparation method comprises the following steps: mixing polylactic acid, chitosan, super-antibacterial polyvinyl alcohol 1, a compatilizer polyvinyl alcohol grafted modified poly-L-lactic acid and polycaprolactone, an antioxidant and a lubricant in a high-speed mixer to obtain a material 1; adding the material 1 into a parallel double-screw extruder from a main feeding hole, and granulating to obtain a granular material 2; performing vacuum drying on the material 2 to obtain a material 3; and putting the material 3 into a screw type spinning machine for melt spinning to obtain the antibacterial degradable fiber. The antibacterial functional components chitosan and polyvinyl alcohol are well combined with a water-soluble degradable fiber base material, so that good functionality, spinnability and mechanical strength are achieved at the same time. The prepared material has the characteristics of high antibacterial property, wide antibacterial spectrum, low cost, environment friendliness and the like, and has a good market application prospect.

The invention discloses an antihypertensive material for subcutaneous implantation and a preparation method of the antihypertensive material, and belongs to the technical field of biomedical materials. The antihypertensive material comprises a carrier material and a drug mixture loaded on the carrier material according to a mass ratio of (10-15): (5-8), and the carrier material comprises the following raw materials: polylactic acid-glycolic acid copolymer, citric acid-chitosan ester, genipin and a silicon dioxide active material. The silicon dioxide active material is obtained by compounding mesoporous silicon dioxide nanoparticles and a collagen coating on the surface of the mesoporous silicon dioxide nanoparticles. According to the antihypertensive material disclosed by the invention, a degradable skeleton is provided by the polylactic acid-glycolic acid copolymer, citric acid-chitosan ester is used as a toughening agent and an antibacterial material, genipin is used as a cross-linking agent, and a mesoporous structure of a silicon dioxide active material is used for loading a medicine; the problems that an existing subcutaneous implant material is high in burst release rate, poor in mechanical property, insufficient in biocompatibility and the like are solved.

The invention discloses a novel process for producing a high-quality liquid fertilizer by using an acetylisovaleryltylosin tartrate finished product liquid, and relates to the technical field of fertilizer preparation, and the novel process comprises the following specific steps: step 1, firstly, weighing polyoxyethylene sorbitan fatty acid ester, ethylenediamine tetraacetic acid disodium salt, cellulase and protease, and uniformly stirring; the preparation method has the advantages that the polylactic acid-glycolic acid copolymer serving as a functional high-molecular polymer has good biocompatibility and controlled release performance, and when a solution prepared from the polylactic acid-glycolic acid copolymer is emulsified and mixed with an alginate oligosaccharide solution, a uniform emulsion-like active synergistic carrier solution is formed; the emulsifying and mixing process enables the effective components in the two solutions to be fully and uniformly combined together to form a stable microsphere and micelle structure, so that the continuous and slow release of the acetylisovaleryltylosin tartrate and the synergistic plant growth regulatory factors thereof in the growth cycle of crops can be ensured, the fertilizer effect of the acetylisovaleryltylosin tartrate and the synergistic plant growth regulatory factors thereof can be fully exerted, and the crop quality is improved. Therefore, the problem that the fertilizer efficiency is not obvious in the prior art is effectively solved.

The invention discloses a near-infrared light nano probe as well as a preparation method and application thereof. The preparation method of the near-infrared nano probe comprises the following steps: dissolving polylactic acid-co-acetic acid in an acetonitrile solution, and adding lecithin and 1, 2-dipalmitoyl-sn-glycerol-3-phosphatidyl glycol to obtain a solution A; dissolving indocyanine green in an ethanol solution to obtain a solution B; and mixing the solution A and the solution B, and carrying out ultrasonic treatment to obtain the near-infrared nano probe. The near-infrared light nanoprobe can be used for imaging diagnosis of acute kidney injury, and effectively solves the problems of long diagnosis time, poor stability, high in-vivo clearance rate, low cell absorption rate and the like. Compared with existing ICG nano-particles, the ICG nano-particles are high in biological tissue penetrability, high in resolution ratio, low in phototoxicity and good in fluorescence imaging effect in an acute kidney injury model and have wide application prospects in AKI clinical diagnosis.

The invention belongs to the technical field of biomedicine, and particularly relates to an alpha-cyperone bionic nano preparation as well as a preparation method and application thereof, the alpha-cyperone bionic nano preparation is prepared from a polylactic acid-glycolic acid copolymer, alpha-cyperone, a bionic membrane and follicle-stimulating hormone polypeptide, the biomimetic membrane is characterized in that alpha-cyperone is loaded on a polylactic acid-glycolic acid copolymer, the biomimetic membrane is biologically camouflaged on the outer layer, then the biomimetic membrane is modified by follicle-stimulating hormone polypeptide, and the amino acid sequence of the follicle-stimulating hormone polypeptide is as shown in SEQ ID NO.1. According to the alpha-cyperone bionic nano preparation disclosed by the invention, the alpha-cyperone is loaded by utilizing the polylactic acid-glycolic acid copolymer, so that the alpha-cyperone is easily dissolved in water, and the blood circulation half-life period is prolonged and the targeting capability of an ovary part is improved through biological camouflage of the bionic membrane; the modification of the follicle-stimulating hormone polypeptide further improves the targeting ability to granulosa cells, and liver and kidney toxicity and muscle injury are not found in the experiment process.

The invention relates to the technical field of wound care, in particular to a responsive release microcapsule as well as a preparation method and application thereof. The preparation method comprises the following steps: S1, dissolving a polylactic acid-glycolic acid copolymer in an organic solvent, adding an emulsifier, and carrying out ultrasonic emulsification to form a water-in-oil emulsion; s2, mixing a polyphenol compound, elastin, vegetable fat and probiotic suspension to form a quaternary mixed solution, slowly dropwise adding the quaternary mixed solution into the water-in-oil emulsion, continuing ultrasonic emulsification to form multiple emulsion, and evaporating to remove an organic solvent to obtain a quaternary system active component mixed solution; and S3, dissolving PDMAEMA in deionized water, adding a cross-linking agent, stirring, slowly dropwise adding the quaternary system active component mixed solution, carrying out a cross-linking reaction, and freeze-drying to obtain the responsive release microcapsule. The microcapsule can accurately release corresponding active ingredients according to pH value changes in different stages of wound healing, effectively shorten the wound healing time, improve the healing quality and reduce scar formation.

The invention discloses an anti-fibrosis drug coating degradable woven stent for treating urethrostenosis, the stent is a hollow cylinder formed by spirally weaving wires, the wires are made of biodegradable polymer materials, the surface of the stent is coated with a drug coating, anti-fibrosis drugs are selected as the drugs, and the anti-fibrosis drug coating is made of biodegradable polymer materials. The drug coating is prepared by using an ultrasonic atomization spraying method; the biodegradable polymer material comprises one or a compound of more than one of poly L-lactic acid, poly D, L-lactic acid, poly (L-lactic acid / D, L-lactic acid), poly (glycolide / lactide), poly (glycolide-lactide), poly (L-lactic acid / caprolactone), poly (glycolide / caprolactone), poly (D, L-lactic acid / caprolactone), polydioxanone and the like. The stent body is made into a self-expanding stent by adopting a weaving method; the biodegradable ureteral stent with the drug coating has good biocompatibility, degradability and mechanical property, and has a wide market application prospect.

The present invention provides aprolin acetate microspheres for injection, which contain aprolin acetate and a polymer; wherein the polymer includes a polylactic-co-glycolic acid copolymer; preferably, the average particle size of the aprolin acetate microspheres for injection is ≤45 μm. The present invention also provides aprolin acetate microsphere composition for injection, which contains the aprolin acetate microspheres for injection of the present invention, and a water-soluble polysaccharide or amino acid. The present invention also provides a method for preparing the aprolin acetate microspheres for injection of the present invention. The present invention also provides a method for preparing the aprolin acetate microsphere composition for injection of the present invention. The present invention also provides the use of the aprolin acetate microspheres for injection of the present invention or the aprolin acetate microsphere composition for injection of the present invention. The aprolin acetate microspheres for injection of the present invention have excellent drug loading and release behavior, no burst release phenomenon, and can achieve good in vivo drug efficacy.

The invention discloses a folic acid-polylactic acid double-layer vesicle delivery system for targeting MDSC cells in a focus and a preparation method and application of the folic acid-polylactic acid double-layer vesicle delivery system, the folic acid-polylactic acid double-layer vesicle delivery system comprises an inner-layer vesicle and an outer-layer vesicle, and a contrast agent is contained between the inner-layer vesicle and the outer-layer vesicle; the inner-layer vesicle is formed by self-assembling two block polymers, the outer wall of the inner-layer vesicle is positively charged, the inner-layer vesicle is compounded with an immunoregulation therapeutic gene through electrostatic interaction, the surface of the inner-layer vesicle is modified by an antibody targeting an MDSC cell surface marker, and a therapeutic drug is loaded in the inner-layer vesicle; the outer vesicle is formed by a liposome modified by targeted disintegration enzyme substrate polypeptide-PEG (Polyethylene Glycol). According to the double-layer vesicle delivery system, the delivery regulation range of the COX-2 inhibitor and folic acid targeted immunotherapy can be limited to local lesion placenta, the toxicity of immune drugs to pregnant women is effectively reduced, effective immunotherapy of placental diseases is made possible, the current situation that no treatment means are provided for placental dysfunction diseases is remarkably improved, and the application prospect is wide. A new thought is provided for effective immunotherapy of placenta dysfunction diseases.

The invention belongs to the technical field of drug delivery, and particularly relates to an M-coated PLGA-10BX compound as well as a preparation method and application thereof. The preparation method comprises the following steps: preparing 10B-enriched boron nitride (h-10BN); extracting a cell membrane of the macrophage RAW264.7; polylactic acid-glycolic acid copolymer (PLGA) nano particles loaded with h-10BN are prepared; and finally, the bionic nano platform M (at) PLGA-10BN based on the macrophage membrane is prepared. The bionic nano-platform prepared by the invention is uniform in particle size and morphology, has relatively high biological safety, and has no obvious damage to various tissues and visceral organs. The compound can be used as a general platform for boron compound delivery, can also be used as an immune activator, is suitable for intravenous injection administration, and expands the application of boron neutron capture therapy (BNCT) in treatment of glioblastoma (GBM).

The invention discloses a bio-based material composite hose and a preparation method thereof, and belongs to the technical field of aluminum-plastic pipes, the bio-based material composite hose provided by the invention comprises a hose head and a hose body, the hose body is formed by lapping bio-based material composite sheets, the bio-based material composite sheet sequentially comprises an outer polylactic acid film, a bonding layer, an aluminum foil, a bonding layer and an inner polylactic acid film, the outer-layer polylactic acid film or the inner-layer polylactic acid film is prepared from the following components in parts by weight: 70 to 90 parts of polylactic acid, 5 to 20 parts of polyhydroxybutyrate-co-valerate and 10 to 30 parts of long carbon chain terminated hyperbranched polycaprolactone. According to the invention, the modified polylactic acid film with complete biodegradability is used in the composite hose, the modified polylactic acid film can be degraded under the action of microorganisms after the use cycle is ended, the aluminum foil is convenient to recycle, and the biocompatibility of the modified polylactic acid film is more beneficial to the application in food packaging, biological medicine packaging and cosmetic packaging.

The application discloses a preparation method of a dopamine-coated poly(L-lactic acid) piezoelectric biomaterial, S1, ultrasonic dispersion of dopamine hydrochloride in an organic solvent is carried out to obtain a dopamine hydrochloride dispersion liquid; S2, poly(L-lactic acid) powder is added into the dopamine hydrochloride dispersion liquid and stirring is carried out to obtain an electrostatic spinning liquid; S3, bubbles in the electrostatic spinning liquid are removed, a nanofiber membrane is obtained through an electrostatic spinning process, high-temperature annealing is carried out on the nanofiber membrane, and cooling is carried out, so that the dopamine-coated poly(L-lactic acid) piezoelectric biomaterial is prepared. The preparation method adopts an interface anchoring effect, strong intermolecular interaction at an interface between dopamine and poly(L-lactic acid) is responsible for anchoring self-polarization poly(L-lactic acid) chains and promoting crystal nucleation, so that the prepared piezoelectric biomaterial exhibits significantly enhanced piezoelectric performance and excellent service life.

The present invention provides a conjugate comprising: (a) a CNS targeting ligand, (b) a hydrophilic polymer of polyethylene glycol (PEG), polylactic acid (PLA), polylactic acid-co-glycolic acid (PLGA), or glucan, and (c) a flavonoid. The present invention also provides a micelle nanoparticle composition comprising: (a) an outer shell comprising the conjugate, optionally (b) an inner shell comprising oligomeric (-)-epigallocatechin gallate (OEGCG), and optionally (c) a CNS disease treatment molecule encapsulated in the inner shell. The invention also provides a method of treating a CNS disease by administering to a subject an effective amount of a nanoparticle composition of the invention. The CNS targeting ligand targets a CNS tissue and delivers an active ingredient to the CNS tissue for treating a CNS pathological condition.

The invention relates to the technical field of compounds, in particular to poly-L-lactic acid microspheres for injection and a preparation method of the poly-L-lactic acid microspheres. The microspheres prepared under the condition of high-speed shearing dispersion or mechanical stirring are uniform in particle size, narrow in particle size range and good in reproducibility. A polylactic acid raw material with proper molecular weight is screened, microspheres are manufactured through a membrane emulsification method, then the microspheres with the required particle size are screened through a screening mechanism, and the surfaces of the microspheres are smooth.

The invention relates to the technical field of medicines, and discloses pedunculoside temperature-sensitive injectable hydrogel as well as a preparation method and application thereof. Specifically, the invention provides application of the temperature-sensitive injectable hydrogel with the pedunculoside in preparation of the medicine for treating the cardiovascular diseases, and the temperature-sensitive injectable hydrogel with the pedunculoside comprises the pedunculoside, a lactic acid-glycolic acid copolymer, polyvinyl alcohol and dipolylactic acid-glycolic acid copolymer polyethylene glycol. The microsphere-gel combined delivery preparation PE-M / Ge prepared by the preparation method disclosed by the invention is good in injectability and has a good temperature-sensitive gelling characteristic in vitro; the obvious gel property is realized, and the microspheres are uniformly distributed in the gel; the release of the drug can be effectively reduced, the release curve is closer to zero-order release, the dual controlled release system can more stably release the drug, the toxic and side effects caused by non-characteristic distribution of PE are reduced, and the bioavailability is improved. And the PE-M / Ge has no cytotoxicity to H9c2 cells and HUVECs cells, so that a foundation is laid for in-vivo pharmacodynamic experiments of rats.

The present invention discloses drug-loaded nanoparticles targeting neuraminidase, as well as a preparation method and application thereof, belonging to the technical field of pharmaceutical preparations. The present invention connects polysialic acid and polylactic acid glycolic acid via an ester bond to obtain drug-loaded nanoparticles with stable structure and performance. The drug-loaded nanoparticles have the function of targeting neuraminidase and have relatively high efficiency in entering cells. Furthermore, antibiotics are dispersed in the drug-loaded nanoparticles, and an inflammatory modulator is adsorbed on the surface of the drug-loaded nanoparticles. The drug-loaded nanoparticles can deliver the antibiotics and the inflammatory modulator to Grasseria suis in pigs, releasing the antibiotics and the inflammatory modulator in the slightly acidic environment of the infected site in the pig, thereby efficiently killing Grasseria suis and reducing inflammatory damage caused by bacterial infection and toxic damage of the antibiotics. Therefore, the present invention has good application prospects in the preparation of drugs for preventing and / or treating Grasseria suis infection.

The present invention relates to a sustained release microsphere and a sustained release preparation comprising a GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof. The present invention relates to a sustained release formulation, and more specifically, to a sustained release formulation comprising a GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof, the sustained-release microparticles comprise a GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof, one kind of low-viscosity polylactic acid-glycolic acid copolymer (PLGA) having an intrinsic viscosity of 0.14 dL / g to 0.24 dL / g, and two or more kinds of high-viscosity polylactic acid-glycolic acid copolymers having an intrinsic viscosity of 0.32 dL / g to 0.60 dL / g, so that the sustained-release microparticles do not have the problems of excessive release and delayed release in the initial stage of a drug. Long-term sustained release can be realized, and the bioavailability is excellent.

The invention relates to the technical field of biomedicine, in particular to siRNA (small interfering ribonucleic acid) for interfering Tc11a gene expression, a core-shell type nano particle as well as a preparation method and application of the core-shell type nano particle. The invention relates to a method for treating type I diabetes mellitus by using core-shell nanoparticles (siTc11a NPs) of a targeted mouse Tc11a gene on an NOD model mouse, and provides a preparation method of the nanoparticles. The preparation method comprises the following steps: mixing siRNA (small interfering ribonucleic acid) interfering with a Tc11a gene with cationic liposome G0-C14 to obtain a complex; mixing the complex with a polylactic acid-glycolic acid copolymer to obtain a core substance; and mixing the core substance with the lipid polymer to obtain the core-shell nanoparticles. The invention provides a treatment strategy for treating the type I diabetes mellitus through targeted Tcl1a gene regulation and control.

The invention belongs to the technical field of biomedicine, and particularly relates to a bionic PLGA composite nano-material and a preparation method and application thereof.The bionic PLGA composite nano-material is characterized in that after curcumin and iloumab are co-loaded and packaged through a polylactic acid-glycolic acid copolymer, a bionic membrane is disguised on the outer layer of the polylactic acid-glycolic acid copolymer; and modifying the surface of the biomimetic membrane with phosphatidylated hyaluronic acid. According to the biomimetic PLGA composite nano-material disclosed by the invention, by utilizing the design characteristics of biomimetic membrane and hyaluronic acid modification and combining two anti-atherosclerosis effects of curcumin and iloumab with different mechanisms, the specific aggregation and permeation of a drug at a diseased region are realized, and the bioavailability of a target cell to the drug is improved; the purpose of treating atherosclerosis through synergistic interaction is achieved.